|
C5ORF42 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.874790E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.353200E-01 |
| Normal-vs-Stage2 |
1.686340E-02 |
| Normal-vs-Stage3 |
1.134020E-01 |
| Normal-vs-Stage4 |
6.061900E-02 |
| Stage1-vs-Stage2 |
2.292100E-02 |
| Stage1-vs-Stage3 |
1.440180E-01 |
| Stage1-vs-Stage4 |
7.687500E-02 |
| Stage2-vs-Stage3 |
1.722820E-01 |
| Stage2-vs-Stage4 |
3.810400E-01 |
| Stage3-vs-Stage4 |
6.645400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.494000E-01 |
| Normal-vs-AfricanAmerican |
3.502400E-01 |
| Normal-vs-Asian |
8.059000E-01 |
| Caucasian-vs-AfricanAmerican |
7.483800E-01 |
| Caucasian-vs-Asian |
3.615600E-01 |
| AfricanAmerican-vs-Asian |
4.038000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.885400E-01 |
| Normal-vs-Female |
1.749830E-01 |
| Male-vs-Female |
7.322800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.794800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.724840E-01 |
| Normal-vs-Age(61-80Yrs) |
8.639000E-03 |
| Normal-vs-Age(81-100Yrs) |
5.821800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.138010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.082600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.364300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.418970E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.419700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.578600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.237400E-03 |
| Classical-VS-Follicular |
6.30939966939081E-10 |
| Classical-VS-Other |
8.514200E-01 |
| Classical-VS-Normal |
5.739600E-01 |
| Tall-VS-Follicular |
1.983950E-02 |
| Tall-VS-Other |
3.681800E-01 |
| Tall-VS-Normal |
6.700400E-02 |
| Follicular-VS-Other |
2.364200E-02 |
| Follicular-VS-Normal |
1.83336999999284E-05 |
| Other-VS-Normal |
7.673000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.394100E-02 |
| Normal-vs-N1 |
9.455800E-01 |
| N0-vs-N1 |
6.184200E-02 |
|
|
